Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | JAK3 |
| Upstream (Parents) |
|---|
| (<<) ARHGAP25 → JAK3 |
| (<<) CD4 → JAK3 |
| (<<) INPP5D → JAK3 |
| (<<) LTB → JAK3 |
| (<<) PRKCB → JAK3 |
| (<<) PTGER4 → JAK3 |
| (<<) STAT4 → JAK3 |
| Downstream (Children) |
|---|
| JAK3 → ARID3B (>>) |
| JAK3 → BCL2 (>>) |
| JAK3 → CASP4 (>>) |
| JAK3 → CCND2 (>>) |
| JAK3 → CD274 (>>) |
| JAK3 → CLCA4 (>>) |
| JAK3 → CORO1A (>>) |
| JAK3 → EFHD2 (>>) |
| JAK3 → FZD2 (>>) |
| JAK3 → GBP2 (>>) |
| JAK3 → GRK5 (>>) |
| JAK3 → HLA-A (>>) |
| JAK3 → HLA-F (>>) |
| JAK3 → ICAM2 (>>) |
| JAK3 → IRF1 (>>) |
| JAK3 → KIAA1949 (>>) |
| JAK3 → LCP1 (>>) |
| JAK3 → LIPG (>>) |
| JAK3 → LPXN (>>) |
| JAK3 → MAL (>>) |
| JAK3 → MOBKL2C (>>) |
| JAK3 → NRN1 (>>) |
| JAK3 → PAG1 (>>) |
| JAK3 → PIK3CD (>>) |
| JAK3 → PIK3R5 (>>) |
| JAK3 → PRKCH (>>) |
| JAK3 → PSTPIP1 (>>) |
| JAK3 → PTK2B (>>) |
| JAK3 → PTK7 (>>) |
| JAK3 → RASSF5 (>>) |
| JAK3 → RHOG (>>) |
| JAK3 → SOCS1 (>>) |
| JAK3 → SQLE (>>) |
| JAK3 → STAT2 (>>) |
| JAK3 → TCEB1 (>>) |
| JAK3 → TGM2 (>>) |
| JAK3 → TNFAIP3 (>>) |
| JAK3 → TRAF1 (>>) |
| JAK3 → TRAF6 (>>) |
| JAK3 → VAV1 (>>) |
| JAK3 → ZBED2 (>>) |
